South Florida Research Phase I-IV — Miami Springs, Florida

South Florida Research Phase I-IV is a clinical research site located in Miami Springs, Florida, United States 33166.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

South Florida Research Phase I-IV has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Iron Deficiency Anemia, Bipolar Disorder Type I With Mania, Endometrial Related Pain.

Sponsors: American Regent, Inc., Bristol-Myers Squibb, Tanabe Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Florida Research Phase I-IV?

South Florida Research Phase I-IV has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Florida Research Phase I-IV conducted?

South Florida Research Phase I-IV has 8 clinical trials on record, with 3 currently active. Their work covers Iron Deficiency Anemia, Bipolar Disorder Type I With Mania, Endometrial Related Pain.

Is South Florida Research Phase I-IV accredited by Crixeo Health?

Yes — South Florida Research Phase I-IV holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about South Florida Research Phase I-IV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.